REG - AstraZeneca PLC - Holding(s) in Company <Origin Href="QuoteRef">AZN.L</Origin>

AstraZenecaAnnouncement

15/07/2015 17:29

RNS Number : 0910N
AstraZeneca PLC
13 May 2015

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi


1. Identity of the issuer or the underlying issuer
of existing shares to which voting rights are
attached:ii
AstraZeneca PLC
2 Reason for the notification (please tick the appropriate box or boxes): 
An acquisition or disposal of voting rights
An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached
An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments
An event changing the breakdown of voting rights
Other (please specify):

3. Full name of person(s) subject to the
notification obligation:iii
The Capital Group Companies, Inc.
4. Full name of shareholder(s)
(if different from 3.):iv
See Schedule A
5. Date of the transaction and date on
which the threshold is crossed or
reached:v
11 May 2015
6. Date on which issuer notified:
12 May 2015
7. Threshold(s) that is/are crossed or
reached: vi, vii
Above 3%


8. Notified details:
A: Voting rights attached to sharesviii, ix
Class/type of
shares

if possible using
the ISIN CODE
Situation previous
to the triggering
transaction
Resulting situation after the triggering transaction
Number
of
Shares
Number
of
Voting
Rights
Number
of shares
Number of voting
rights
% of voting rights x
Direct
Direct xi
Indirect xii
Direct
Indirect
Ordinary Shares
(ISIN: GB0009895292)
32,100,333
32,100,333


32,139,533

2.544%
ADRs 
(ISIN: US0463531089)
5,767,760
5,767,760


5,768,891

0.457%

B: Qualifying Financial Instruments
Resulting situation after the triggering transaction
Type of financial
instrument
Expiration
date xiii
Exercise/
Conversion Period xiv
Number of voting
rights that may be
acquired if the
instrument is
exercised/ converted.
% of voting
rights






C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi
Resulting situation after the triggering transaction
Type of financial
instrument
Exercise price
Expiration date xvii
Exercise/
Conversion period xviii
Number of voting rights instrument refers to
% of voting rights xix, xx




Nominal
Delta



Total (A+B+C)
Number of voting rights
Percentage of voting rights
37,908,424
3.000%


9. Chain of controlled undertakings through which the voting rights and/or the
financial instruments are effectively held, if applicable: xxi
See Schedule A

Proxy Voting:
10. Name of the proxy holder:

11. Number of voting rights proxy holder will cease
to hold:

12. Date on which proxy holder will cease to hold
voting rights:



13. Additional information:


14. Contact name:
Martin Bennett, Assistant Company Secretary
15. Contact telephone number:
020 7604 8157


Schedule A
As of 11 May 2015
AstraZeneca PLC

Number of Shares
Percent of Outstanding



The Capital Group Companies, Inc. ("CG") holdings
37,908,424
3.000%
Holdings by CG Management Companies and Funds:


Capital Guardian Trust Company
5,439,762
0.431%
Capital International Limited
165,000
0.013%
Capital International Srl
153,792
0.012%
Capital International, Inc.
72,300
0.006%
Capital Research and Management Company
32,077,570
2.539%

This information is provided by RNS
The company news service from the London Stock Exchange
  END
HOLBXGDUCSBBGUX